Thomas Schall
Net worth: 371 905 $ as of 2026-06-29
Net worth: 371 905 $ as of 2026-06-29
Thomas J.
Schall was the founder of ChemoCentryx, Inc., founded in 1997, where the titles held included Chairman, President & Chief Executive Officer from 2012 to 2022.
The current job is Chairman at Immuneering Corp., starting in 2025.
Former jobs include Scientist at Genentech, Inc., and Principal at DNAX Research, Inc. from 1993 to 1997.
Education includes a doctorate from Stanford University and an undergraduate degree from Northern Illinois University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 74,530 ( 0.12% ) | 371 905 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| IMMUNEERING CORPORATION | Chairman | 2025-09-15 |
| Companies | Position | End |
|---|---|---|
| CHEMOCENTRYX, INC. | Chief Executive Officer | 2022-10-19 |
DNAX Research, Inc. | Corporate Officer/Principal | 1996-12-31 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northern Illinois University
Northern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNAX Research, Inc. | |
Immuneering Corp.
Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Select your edition
All financial news and data tailored to specific country editions